IECM
TECH icon

Intrinsic Edge Capital Management’s Bio-Techne TECH Stock Holding History

Intrinsic Edge Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-110,000
Closed -$5.75M – 145
2026
Q1 		$5.75M Buy
+110,000
New +$6.6M 0.95% 42
2017
Q3 		– Sell
-20,000
Closed -$588K – 148
2017
Q2 		$588K Buy
+20,000
New +$547K 0.18% 104

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Intrinsic Edge Capital Management's TECH Position: Q2 2026 in Review

Intrinsic Edge Capital Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 110,000 shares — an estimated $5.75M sold.

Intrinsic Edge Capital Management first reported a position in TECH in Q2 2017 and held it in 2 quarters. The position peaked at $5.75M in Q1 2026. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Intrinsic Edge Capital Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 110,000 Bio-Techne shares in Q2 2026, an estimated $5.75M.
  • Intrinsic Edge Capital Management first reported a position in Bio-Techne in Q2 2017 and held it in 2 quarters.
  • Intrinsic Edge Capital Management's Bio-Techne position peaked at $5.75M in Q1 2026.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Intrinsic Edge Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.